Thyroid Follicular Epithelial Cell–Derived Cancer: New Approaches and Treatment Strategies

Controversies, Consensus and Collaboration in the Use of I-131 Therapy in Differentiated Thyroid Cancer:

(2019) R Michael Tuttle et al.   THYROID

Telomerase and Telomeres Biology in Thyroid Cancer

(2019) Benedetta Donati et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Optimal Thyrotropin Suppression Therapy in Low-Risk Thyroid Cancer Patients after Lobectomy

(2019) Lee et al.   Journal of Clinical Medicine

Controversial Issues in Thyroid Cancer Management

(2018) R. Michael Tuttle   JOURNAL OF NUCLEAR MEDICINE

Metastatic Hurthle cell cancer

(2018) A S A de Melo et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Differentiated Thyroid Cancer—Treatment: State of the Art

(2017) Benedikt Schmidbauer et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience

(2016) Nikola Besic et al.   BMC CANCER

Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer

(2016) Mingzhao Xing   BMC Medicine

The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients

(2016) Carrie C. Lubitz et al.   CANCER

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes

(2016) Gustavo C. Penna et al.   CYTOGENETIC AND GENOME RESEARCH

Thyroid nodules and cancer management guidelines: comparisons and controversies

(2016) Fadi Nabhan et al.   ENDOCRINE-RELATED CANCER

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers

(2016) Iñigo Landa et al.   JOURNAL OF CLINICAL INVESTIGATION

Thyroid cancer

(2016) Maria E Cabanillas et al.   LANCET

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

(2016) Bryan R. Haugen et al.   THYROID

Pediatric papillary thyroid cancer: current management challenges

(2016) Frederik A. Verburg et al.   OncoTargets and Therapy

Hürthle cell carcinoma: current perspectives

(2016) Sara Ahmadi et al.   OncoTargets and Therapy

Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib--Response

(2015) S. M. Rothenberg et al.   CLINICAL CANCER RESEARCH

Follicular Thyroid Carcinoma: How Have Histologic Diagnoses Changed in the Last Half-Century and What Are the Prognostic Implications?

(2015) Nicole A. Cipriani et al.   THYROID

Chemoradiation in anaplastic thyroid carcinomas

(2012) X.S. Sun et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma

(2012) Cristina Romei et al.   Frontiers in Endocrinology

Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

(2011) Paula Soares et al.   CURRENT GENOMICS

The Significance of Hurthle Cells in Thyroid Disease

(2011) J. Cannon   ONCOLOGIST

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies

(2009) Maria Chiara Zatelli et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Regulation of Uptake of 18F-FDG by a Follicular Human Thyroid Cancer Cell Line with Mutation-Activated K-Ras

(2009) O. Prante et al.   JOURNAL OF NUCLEAR MEDICINE

Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer

(2008) Y. Wang et al.   ENDOCRINE-RELATED CANCER